Notice of Lead Plaintiff Deadline for Shareholders in the eHealth, Inc. Securities Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that a securities class action lawsuit has been filed in the Northern District of California on behalf of purchasers of eHealth, Inc. (NASDAQ:EHTH) common stock between March 19, 2018 and April 7, 2020 (the “Class Period”). The case is captioned Patel v. eHealth, Inc., No. 20-cv-2395, and is assigned to Judge Jon S. Tigar. The eHealth securities class action lawsuit charges eHealth and certain of its officers with violations of the Securities Exchange Act of 1934.

The Private Securities Litigation Reform Act of 1995 permits any investor who purchased eHealth common stock during the Class Period to seek appointment as lead plaintiff in the eHealth securities class action lawsuit. A lead plaintiff acts on behalf of all other class members in directing the eHealth securities class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the eHealth securities class action lawsuit. An investor’s ability to share in any potential future recovery of the eHealth securities class action lawsuit is not dependent upon serving as lead plaintiff. If you wish to serve as lead plaintiff of the eHealth securities class action lawsuit or have questions concerning your rights regarding the eHealth securities class action lawsuit, please visit our website by clicking here or contact Brian Cochran at 800/449-4900 or 619/231-1058, or via e-mail at [e-mail]. Lead plaintiff motions for the eHealth securities class action lawsuit must be filed with the court no later than June 8, 2020.

eHealth is a health insurance marketplace with a technology and service platform that provides consumer engagement, education, and health insurance enrollment solutions.

The eHealth securities class action alleges that during the Class period, defendants misrepresented and/or failed to disclose adverse information regarding eHealth’s business and operations, including information regarding eHealth’s highly aggressive accounting and modeling assumptions, its skyrocketing rate of member churn resulting from eHealth’s pursuit of low quality, loss-making growth, and its reliance on direct-response television advertising, which attracts unprofitable, high-churn enrollees. As a result of defendants’ misrepresentations and omissions, the price of eHealth common stock was artificially inflated to more than $146 per share during the Class Period.